Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective

doi:10.4251/wjgo.v16.i11.4489

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1158)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-5) series.

Item

Count

PDF

HTML

659

Figures (1-7)

Tables (1-5)

Sum=848

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=162

Publishing Process of This Article

Item

Count

Browse

Download

Sum=110

Nov 15, 2024 (publication date) through Jan 8, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Scientometrics

World J Gastrointest Oncol. Nov 15, 2024; 16(11): 4489-4505
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4489

Full Size Figure Download Figure

Figure 7 The top 12 clustering terms of olaparib and pancreatic cancer and the keyword trends. A: Density map of the co-occurrence analysis of keywords. The word size, circle size, and opacity of color are positively related to frequency; B: Cluster analysis of keywords; C: Keyword timeline map of 12 clusters; D: The top 11 keywords with the strongest bursts.

Citation: Feng X, Chai YH, Jiang KX, Jiang WB, Chen WC, Pan Y. Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective. World J Gastrointest Oncol 2024; 16(11): 4489-4505
URL: https://www.wjgnet.com/1948-5204/full/v16/i11/4489.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i11.4489